Author:
William Basem M.,de Lima Marcos
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference69 articles.
1. Shapira MY, Tsirigotis P, Resnick IB, Or R, Abdul-Hai A, Slavin S. Allogeneic hematopoietic stem cell transplantation in the elderly. Crit Rev Oncol Hematol. 2007;64(1):49–63.
2. de Lima M, Champlin R. Unrelated donor hematopoietic transplantation. Rev Clin Exp Hematol. 2001;5(2):100–34.
3. Wong R, Giralt SA, Martin T, Couriel DR, Anagnostopoulos A, Hosing C, et al. Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood. 2003;102(8):3052–9.
4. Labopin M, Latouche A, Suciu S, Santucci A, Canals C, Iacobelli S, et al. Definitions and evaluation of endpoints following stem cells transplantation—recommendation from the European Group for Blood and Marrow Transplantation (EBMT). Establishment of infrastructure to support International Prospective Clinical Trials in Stem Cell Transplantation (CLINT) Work Package 5. http://portal.ebmt.org/sites/clint2/clint/Documents/Statistical%20Endpoints_CLINT%20Project_final%20version.pdf . Cited 03/03/2013.
5. Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol. 1998;16(12):3796–802.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献